BSE: APLLTD - Alembic Pharmaceuticals Limited

Rentabilidade por seis meses: -29.58%
Rendimento de dividendos: +0.87%

Cronograma de promoção Alembic Pharmaceuticals Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products.

mais detalhes
The company was founded in 1907 and is headquartered in Vadodara, India.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

ISIN INE901L01018
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.8659
Дивиденд ао 11
Сайт https://alembicpharmaceuticals.com
Цена ао 827.95
Alteração de preço por dia: +0.5556% (827.95)
Alteração de preço por semana: -1.55% (845.65)
Alteração de preço por mês: -1.5% (845.2)
Alteração de preço em 3 meses: -21.56% (1061.35)
Mudança de preço em seis meses: -29.58% (1182.3)
Mudança de preço por ano: -9.27% (917.65)
Mudança de preço em 3 anos: +15.2% (722.7)
Mudança de preço em 5 anos: +31.84% (631.5)
Mudança de preço em 10 anos: 0% (832.55)
Mudança de preço desde o início do ano: -19.66% (1036.3)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.49 6
P/BV 3.16 5
P/E 24.69 6
EV/EBITDA 17.77 6
Total: 6.5

Eficiência

Nome Significado Nota
ROA, % 9.55 3
ROE, % 12.78 4
Total: 2.5

Dividendos

Nome Significado Nota
Div yield, % 0.8659 2.18
DSI 0.8571 8.57
Total: 4.14

Obrigação

Nome Significado Nota
Debt/EBITDA 1.06 8
Total: 9.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 32.71 5
Rentabilidade Ebitda, % -41.82 0
Rentabilidade EPS, % -18.89 0
Total: 1
Mais detalhes

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
iShares MSCI India Small-Cap ETF 0.15813 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07481 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.05587 7.67 2.7853
WisdomTree India Earnings Fund 0.04848 5.23 1.65591
WisdomTree Emerging Markets SmallCap Dividend Fund 0.04404 1.35 5.00999
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Dimensional Emerging Markets Value ETF 0.01002 17.07 4.19508
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00961 12.46 3.59676
Dimensional Emerging Markets Core Equity 2 ETF 0.00845 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.00806 8.77 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.00439 13.06 3.62488
SPDR Portfolio Emerging Markets ETF 0.00394 11.59 3.1879
Vanguard ESG International Stock ETF 0 6.39 3.07501

Supervisor Cargo Pagamento Ano de nascimento
Mr. Pranav Chirayu Amin Managing Director 122.2M 1975 (50 anos)
Mr. Shaunak Chirayu Amin MD & Executive Director 122.2M 1978 (47 anos)
Mr. Vinod Kamath President of Operations N/A
Dr. J. Venkat Raman M. S., Ph.D. Chief Scientific Officer N/A 1958 (67 anos)
Ms. Manisha Saraf Company Secretary & Compliance Officer N/A
Mr. Udit C. Amin Chief Business Development Officer N/A 1980 (45 anos)
Mr. Gautam Chatterjee Senior Vice President N/A 1961 (64 ano)
Mr. Chirayu Ramanbhai Amin Executive Chairman & CEO 88M 1946 (79 anos)
Mr. Raj Kumar Shreeram Baheti B.Com.(Hon.), FCA, FCS Director of Finance, CFO & Executive Director 1959 (66 anos)
Mr. Ajay Kumar Desai Senior Vice President of Finance

Endereço: India, Vadodara, Alembic Road - abrir no Google Maps, abrir mapas Yandex
Site: https://alembicpharmaceuticals.com